ResearcherGuangxi Medical UniversityActive in the last 2 years
Haixing Jiang
Matched on ORCID iD 0000-0003-2974-2035; OpenAlex author ID A5002968699, A5018705727. Sources: OpenAlex.
Their work
- Papers
- 18 (first author 2, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 17
2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 3 papers · 2023: 4 papers · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers
Papers 18
- The effect of HBE1 on resistance to gemcitabine in pancreatic cancer cells. First author DOI 10.1016/j.ajg.2026.01.006↗
- Oncostatin M promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 via the PI3K/AKT pathway. Co-author DOI 10.1016/j.ijbiomac.2026.152179↗
- IL-15 promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 expression via the JAK1/STAT1/IRF1 pathway. Co-author DOI 10.1186/s12964-026-02870-8↗
- An endoscopic ultrasound-based interpretable deep learning model and nomogram for distinguishing pancreatic neuroendocrine tumors from pancreatic cancer. Last author DOI 10.1038/s41598-024-84749-7↗
- EUS-based intratumoral and peritumoral machine learning radiomics analysis for distinguishing pancreatic neuroendocrine tumors from pancreatic cancer. Co-author DOI 10.3389/fonc.2025.1442209↗
- Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. Last author DOI 10.1038/s41598-024-75089-7↗
- Construction and validation of an endoscopic ultrasonography-based ultrasomics nomogram for differentiating pancreatic neuroendocrine tumors from pancreatic ca… Co-author DOI 10.3389/fonc.2024.1359364↗
- Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2023/5145152↗
- Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer. Co-author DOI 10.1186/s12885-023-10749-x↗
- Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-Sensitive Hydrogel. Co-author DOI 10.2147/ijn.s417445↗
- Erratum: Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-Sensitive Hydrogel [Corrigendum… Co-author DOI 10.2147/ijn.s437867↗
- IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway. Co-author DOI 10.1007/s12094-021-02748-w↗
- The effect and mechanism of miR-30e-5p targeting SNAI1 to regulate epithelial-mesenchymal transition on pancreatic cancer. Last author DOI 10.1080/21655979.2022.2050880↗
- LncRNA A2M-AS1 Promotes Ferroptosis in Pancreatic Cancer via Interacting With PCBP3. Co-author DOI 10.1158/1541-7786.mcr-22-0024↗
- Identification of a Five-Gene Prognostic Signature Related to B Cells Infiltration in Pancreatic Adenocarcinoma. Co-author DOI 10.2147/ijgm.s324432↗
- Relationship between a 7-mRNA signature of the pancreatic adenocarcinoma microenvironment and patient prognosis (a STROBE-compliant article). First author DOI 10.1097/md.0000000000021287↗
- Identification of Hub Prognosis-Associated Oxidative Stress Genes in Pancreatic Cancer Using Integrated Bioinformatics Analysis. Co-author DOI 10.3389/fgene.2020.595361↗
- Identification of novel therapeutic target genes and pathway in pancreatic cancer by integrative analysis. Co-author DOI 10.1097/md.0000000000008261↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shanyu Qin · 16 shared papers, 2017–2026 · strength 3.28
- Paper The effect of HBE1 on resistance to gemcitabine in pancreatic cancer cells. DOI 10.1016/j.ajg.2026.01.006↗
- Paper An endoscopic ultrasound-based interpretable deep learning model and nomogram for distinguishing pancreatic neuroendocr… DOI 10.1038/s41598-024-84749-7↗
- Paper EUS-based intratumoral and peritumoral machine learning radiomics analysis for distinguishing pancreatic neuroendocrine… DOI 10.3389/fonc.2025.1442209↗
- Jing Ning · 6 shared papers, 2023–2026 · strength 1.55
- Paper Oncostatin M promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 via the PI3K/A… DOI 10.1016/j.ijbiomac.2026.152179↗
- Paper IL-15 promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 expression via the JA… DOI 10.1186/s12964-026-02870-8↗
- Paper Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. DOI 10.1038/s41598-024-75089-7↗
- Shuangyang Mo · 3 shared papers, 2024–2025 · strength 0.75
- Paper An endoscopic ultrasound-based interpretable deep learning model and nomogram for distinguishing pancreatic neuroendocr… DOI 10.1038/s41598-024-84749-7↗
- Paper EUS-based intratumoral and peritumoral machine learning radiomics analysis for distinguishing pancreatic neuroendocrine… DOI 10.3389/fonc.2025.1442209↗
- Paper Construction and validation of an endoscopic ultrasonography-based ultrasomics nomogram for differentiating pancreatic … DOI 10.3389/fonc.2024.1359364↗
- Dan Yang · 3 shared papers, 2023–2024 · strength 0.72
- Paper Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. DOI 10.1038/s41598-024-75089-7↗
- Paper Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-… DOI 10.2147/ijn.s417445↗
- Paper Erratum: Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradabl… DOI 10.2147/ijn.s437867↗
- Xiubing Chen · 2 shared papers, 2026 · strength 0.67
- Paper Oncostatin M promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 via the PI3K/A… DOI 10.1016/j.ijbiomac.2026.152179↗
- Paper IL-15 promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 expression via the JA… DOI 10.1186/s12964-026-02870-8↗
- Weiwei Zhang · 2 shared papers, 2026 · strength 0.67
- Paper Oncostatin M promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 via the PI3K/A… DOI 10.1016/j.ijbiomac.2026.152179↗
- Paper IL-15 promotes immune escape, invasion, and metastasis of pancreatic cancer by upregulating PD-L1 expression via the JA… DOI 10.1186/s12964-026-02870-8↗
- Xiubing Chen · 3 shared papers, 2023–2024 · strength 0.60
- Paper Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. DOI 10.1038/s41598-024-75089-7↗
- Paper Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adeno… DOI 10.1155/2023/5145152↗
- Paper Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic can… DOI 10.1186/s12885-023-10749-x↗
- Yi Nan · 2 shared papers, 2025 · strength 0.52
- Paper An endoscopic ultrasound-based interpretable deep learning model and nomogram for distinguishing pancreatic neuroendocr… DOI 10.1038/s41598-024-84749-7↗
- Paper EUS-based intratumoral and peritumoral machine learning radiomics analysis for distinguishing pancreatic neuroendocrine… DOI 10.3389/fonc.2025.1442209↗
- Shaomei Tang · 2 shared papers, 2021–2022 · strength 0.38
- Paper Identification of a Five-Gene Prognostic Signature Related to B Cells Infiltration in Pancreatic Adenocarcinoma. DOI 10.2147/ijgm.s324432↗
- Paper The effect and mechanism of miR-30e-5p targeting SNAI1 to regulate epithelial-mesenchymal transition on pancreatic canc… DOI 10.1080/21655979.2022.2050880↗
- Xianglian Zhang · 2 shared papers, 2020–2022 · strength 0.35
- Xin Qiu · 2 shared papers, 2020–2022 · strength 0.33
- Jiyun Cheng · 1 shared paper, 2026 · strength 0.32
- Ziyu Liang · 1 shared paper, 2022 · strength 0.19
- Zhe Yang · 1 shared paper, 2023 · strength 0.17
- Shi XY · 1 shared paper, 2022 · strength 0.16
- Qinglin He · 1 shared paper, 2020 · strength 0.16
- Bang-li Hu · 1 shared paper, 2017 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.